•
Sep 30, 2020

Zimmer Biomet Q3 2020 Earnings Report

Reported a 2.0% increase in net sales and diluted earnings per share of $1.16; adjusted diluted earnings per share was $1.81.

Key Takeaways

Zimmer Biomet reported third quarter net sales of $1.929 billion, a 2.0% increase over the prior year, and diluted earnings per share of $1.16. Adjusted diluted earnings per share were $1.81, a 2.3% increase over the prior year.

Third quarter net sales of $1.929 billion increased 2.0%, and increased 1.1% on a constant currency basis

Third quarter net sales of $1.929 billion increased 2.0%, and increased 1.1% on a constant currency basis

Third quarter diluted earnings per share were $1.16; adjusted diluted earnings per share were $1.81

Third quarter diluted earnings per share were $1.16; adjusted diluted earnings per share were $1.81

Total Revenue
$1.93B
Previous year: $1.89B
+2.0%
EPS
$1.81
Previous year: $1.77
+2.3%
Gross Profit
$1.36B
Previous year: $1.36B
+0.2%
Cash and Equivalents
$967M
Previous year: $513M
+88.7%
Free Cash Flow
$287M
Previous year: $519M
-44.7%
Total Assets
$24B
Previous year: $24.3B
-1.2%

Zimmer Biomet

Zimmer Biomet

Zimmer Biomet Revenue by Segment

Zimmer Biomet Revenue by Geographic Location

Forward Guidance

Zimmer Biomet is not providing fourth quarter financial guidance at this time due to the uncertainty around the scope and duration of COVID-19 and its ongoing impact.

Revenue & Expenses

Visualization of income flow from segment revenue to net income